4/A

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: December 21, 2010
Period of Report: December 14, 2010
Accession Number: 0001237899-10-000062

View Document ↗ View on SEC.gov ↗